To characterize the association of LAMC2 and CD82 with the prognosis of GC, the Kaplan–Meier survival curves were applied using 876 GC patients in the KM plots database (http: //www.kmplot.com), and GC patients with higher levels of LAMC2 and/or lower levels of CD82 had longer survival (Figure 5a). This evidence concerns the gene LAMC2 and gastric cancer.